NASDAQ:KIN - Kindred Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$8.27 -0.58 (-6.55 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$8.27
Today's Range$8.27 - $8.84
52-Week Range$8.05 - $15.75
Volume253,816 shs
Average Volume237,178 shs
Market Capitalization$321.29 million
P/E Ratio-5.17
Dividend YieldN/A

Analyst Ratings

Kindred Biosciences (NASDAQ:KIN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Kindred Biosciences in the last 12 months. Their average twelve-month price target is $18.75, suggesting that the stock has a possible upside of 126.72%. The high price target for KIN is $25.00 and the low price target for KIN is $12.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.862.862.78
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.75$20.4375$20.4375$17.1875
Price Target Upside: 126.72% upside81.99% upside50.28% upside29.72% upside

Kindred Biosciences (NASDAQ:KIN) Consensus Price Target History

Price Target History for Kindred Biosciences (NASDAQ:KIN)

Kindred Biosciences (NASDAQ:KIN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/7/2019Lake Street CapitalLower Price TargetBuy$30.00 ➝ $12.00HighView Rating Details
3/7/2019HC WainwrightReiterated RatingBuy$19.00HighView Rating Details
3/5/2019Cantor FitzgeraldReiterated RatingBuy$25.00LowView Rating Details
11/8/2018B. RileyBoost Price TargetBuy$16.00 ➝ $21.00MediumView Rating Details
8/7/2018LADENBURG THALM/SH SHDowngradeBuy ➝ NeutralHighView Rating Details
7/9/2018CL KingUpgradeNeutral ➝ BuyHighView Rating Details
5/23/2018EuroPacific CanadaInitiated CoverageBuy$16.75LowView Rating Details
12/22/2017BMO Capital MarketsReiterated RatingHoldHighView Rating Details
12/15/2017AegisReiterated RatingBuyLowView Rating Details
5/31/2017FBR & CoReiterated RatingBuyLowView Rating Details
(Data available from 3/23/2017 forward)
This page was last updated on 3/23/2019 by Staff

Featured Article: What is the NASDAQ?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel